|
The BinaxNOW® RSV test is one of the easiest tests to run on the market today.
Rapid results are available in 15 minutes with no hands-on time. Critical care instructions
can be provided to parents prior to the child leaving the paediatrician's office and valuable
information can be obtained prior to hospital admission to help control the spread of
RSV infections. Now the focus can be on the results and care of your patients, not running the test.
Intended Use
The BinaxNOW® RSV test is a rapid immunochromatographic assay for the qualitative
detection of respiratory syncytial virus (RSV) fusion protein antigen in nasal wash and
nasopharyngeal (NP) swab specimens from symptomatic patients. This test is intended for
in vitro diagnostic use to aid in the diagnosis of RSV infections in neonatal and paediatric
patients under the age of five. It is recommended that negative test results be confirmed by cell culture.
Product Details
| Sample Type: |
Nasopharyngeal swab, nasal wash |
Time to Result: |
15 minutes |
Kit Size: |
132 tests |
Performance data: |
Nasal Wash Sensitivity/Specificity 89% / 100%*
|
| |
NP SwabSensitivity/Specificity 93% / 93% |
Regulatory: |
Cleared for distribution by the FDA and CE marked, |
| |
available in 11 languages |
About RSV
Respiratory syncytial virus (RSV) is a common cause of upper and lower respiratory tract infections
and the major cause of bronchiolitis and pneumonia in infants and children. Infections and outbreaks
due to RSV typically occur yearly in the fall, winter, and spring. While RSV can cause significant
respiratory illness in older children and adults, the disease tends to be milder in these populations
than in infants and young children.
Rapid identification and diagnosis of RSV has become more important due to the availability of effective
antimicrobial therapy. Rapid identification can lead to reductions in hospital stays, antimicrobial use, and
the cost of hospital care1.
-Order No. MPC 430-100
-FDA 510K & CLIA Waived
-Quantity: 132
-Reimbursement Code/Amount: 87807QW, $16.76
-Reimbursement shown indicates National Average, it is always the medical professional
responsibilty to establish appropriate reimbursements. This product is for professional use
only.
Frequently Asked Questions
Can the BinaxNOW® RSV test be used on samples
from adults?
No, BinaxNOW® RSV has only been validated for use with samples from neonates and
paediatric patients under the age of 5 years.
Can the BinaxNOW® RSV test be read after
15 minutes?
No the results are not stable. If a sample line appears after 15 minutes it must be ignored.
Can nasal aspirate samples be used in the
BinaxNOW® RSV test?
No, the BinaxNOW® RSV test has only been validated with nasal wash and nasopharyngeal swab samples.
Can the BinaxNOW® RSV test be used on
patients being treated with Palivizumab?
No, samples from patients treated with Palivizumab has been shown to interfere with the BinaxNOW® RSV test.
For more information about RSV, please see the links below:
References
1. Williams KM, Jackson MA, Hamilton M. Rapid diagnostic testing for URIs in children:
impact on physician decision making and cost. Infect Med. 2002;19(3):109-111.
*Retrospective data. See package insert for complete performance information.
| 
